Physician profile
Gaurav Kumar
NPI 1588763288
$1,257.77
in general payments reported to CMS, 2019-2025
14 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $52.99 · 2021: $11.56 · 2022: $59.90 · 2023: $105 · 2024: $383 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.28 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $296.85 | 2024-2025 | Azur Cx Detachable |
| Stryker Corporation | $180.69 | 2019-2025 | Flowtriever |
| Inari Medical, INC. | $171.79 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Glaxosmithkline, LLC. | $130.70 | 2020-2025 | Nucala |
| Genentech USA, INC. | $125.00 | 2019 | |
| Penumbra, INC. | $85.00 | 2019 | |
| Boston Scientific Corporation | $74.64 | 2024-2025 | Embold Fibered |
| Actelion Pharmaceuticals US, INC. | $54.99 | 2023 | Uptravi, Opsumit |
| Medtronic, INC. | $36.82 | 2023 | Onyx 18 |
| Pfizer INC. | $31.78 | 2019 | |
| Argon Medical Devices, INC. | $23.78 | 2022 | |
| Angiodynamics, INC. | $19.11 | 2022 | |
| Endocare, INC. | $13.65 | 2019 | |
| W. L. Gore & Associates, INC. | $12.97 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.